Oktober 2021: Cabozantinib (Cabometyx, Exelixis, Inc.) telah disetujui oleh Food and Drug Administration untuk pasien dewasa dan anak-anak berusia 12 tahun ke atas yang memiliki tiroid diferensiasi lanjut atau metastasis lokal.
Lenvatinib (Lenvima) New oral anticancer drug Lenvima (lenvatinib) has recently been approved by Japan for the treatment of unresectable thyroid cancer. This is another important market that the drug has captured since it was app..